<SEC-DOCUMENT>0001193125-23-110578.txt : 20230421
<SEC-HEADER>0001193125-23-110578.hdr.sgml : 20230421
<ACCEPTANCE-DATETIME>20230421162959
ACCESSION NUMBER:		0001193125-23-110578
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230419
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230421
DATE AS OF CHANGE:		20230421

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HCA Healthcare, Inc.
		CENTRAL INDEX KEY:			0000860730
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		IRS NUMBER:				273865930
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11239
		FILM NUMBER:		23836737

	BUSINESS ADDRESS:	
		STREET 1:		ONE PARK PLZ
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		6153449551

	MAIL ADDRESS:	
		STREET 1:		ONE PARK PLAZA
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCA Holdings, Inc.
		DATE OF NAME CHANGE:	20101126

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCA INC/TN
		DATE OF NAME CHANGE:	20010627

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HCA THE HEALTHCARE CO
		DATE OF NAME CHANGE:	20010419
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d423503d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hca="http://www.hcahealthcare.com/20230419" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Form 8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-04-19_to_2023-04-19">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-04-19_to_2023-04-19">0000860730</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="hca-20230419.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-04-19_to_2023-04-19"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000860730</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-04-19</xbrli:startDate> <xbrli:endDate>2023-04-19</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-04-19_to_2023-04-19">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO SECTION 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF THE SECURITIES EXCHANGE ACT OF 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): April&#160;21, 2023 (<ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-04-19_to_2023-04-19" format="ixt:datemonthdayyearen">April 19, 2023</ix:nonNumeric>)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2023-04-19_to_2023-04-19">HCA HEALTHCARE, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-04-19_to_2023-04-19" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-04-19_to_2023-04-19">001-11239</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-04-19_to_2023-04-19">27-3865930</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-04-19_to_2023-04-19">One Park Plaza</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-04-19_to_2023-04-19">Nashville</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-04-19_to_2023-04-19" format="ixt-sec:stateprovnameen">Tennessee</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-04-19_to_2023-04-19">37203</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-04-19_to_2023-04-19">(615)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-04-19_to_2023-04-19">344-9551</ix:nonNumeric></span></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-04-19_to_2023-04-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-04-19_to_2023-04-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-04-19_to_2023-04-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-04-19_to_2023-04-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-04-19_to_2023-04-19">Common Stock, $.01 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-04-19_to_2023-04-19">HCA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-04-19_to_2023-04-19" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (17 CFR <span style="white-space:nowrap">&#167;240.12b-2).</span></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-04-19_to_2023-04-19" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors (the &#8220;Board&#8221;) of HCA Healthcare, Inc. (the &#8220;Company&#8221;) previously approved, subject to stockholder approval, the HCA Healthcare, Inc. 2023 Employee Stock Purchase Plan (the &#8220;2023 Employee Stock Purchase Plan&#8221;). According to the results from the Company&#8217;s Annual Meeting of Stockholders held on April&#160;19, 2023 (as noted in Item 5.07 below), the Company&#8217;s stockholders approved the 2023 Employee Stock Purchase Plan. A detailed summary of the material terms of the 2023 Employee Stock Purchase Plan appears on pages 40 &#8211; 43 of the Company&#8217;s Definitive Proxy Statement on Schedule 14A, which was filed with the Securities and Exchange Commission on March&#160;10, 2023 (the &#8220;Proxy Statement&#8221;), and is incorporated herein by reference. That summary and the foregoing description of the 2023 Employee Stock Purchase Plan do not purport to be complete and are qualified in their entirety by reference to the full text of the 2023 Employee Stock Purchase Plan, a copy of which is attached to this report as Exhibit 10.1 and is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.07.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Submission of Matters to a Vote of Security Holders. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company held its Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) on April&#160;19, 2023 in a virtual meeting format only, via webcast. At the Annual Meeting, a total of 258,296,768 shares of the Company&#8217;s common stock, out of a total of 277,254,591 shares of common stock outstanding and entitled to vote as of the record date for the Annual Meeting, were represented in person or by proxy. Voting results from the Annual Meeting were as follows: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. The following ten director nominees were elected to the Company&#8217;s Board of Directors for a <span style="white-space:nowrap">one-year</span> term, or until such director&#8217;s respective successor is duly elected and qualified or until such director&#8217;s earlier death, resignation or removal, as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:56%"></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom">For</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom">Against</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom">Abstentions</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="white-space:nowrap">Broker&#160;Non-Votes</span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas F. Frist III</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">236,384,150</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,368,755</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">52,692</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,491,171</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Samuel N. Hazen</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">240,497,358</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,251,973</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">56,266</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,491,171</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Meg G. Crofton</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">240,339,619</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,407,995</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">57,983</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,491,171</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert J. Dennis</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">234,067,901</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">7,671,226</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">66,470</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,491,171</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><span style="white-space:nowrap">Nancy-Ann</span> DeParle</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">238,498,682</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,249,759</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">57,156</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,491,171</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William R. Frist</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">239,578,134</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,170,833</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">56,630</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,491,171</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hugh F. Johnston</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">237,527,316</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">4,211,331</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">66,950</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,491,171</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael W. Michelson</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">239,631,253</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,109,882</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">64,462</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,491,171</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wayne J. Riley, M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">236,418,547</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">5,324,531</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">62,519</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,491,171</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Andrea B. Smith</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">240,803,243</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">945,476</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">56,878</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">16,491,171</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. The appointment of Ernst&#160;&amp; Young LLP as the Company&#8217;s independent registered public accounting firm for the year ending December&#160;31, 2023 was ratified as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:86%;border:0;margin:0 auto">


<tr>

<td style="width:24%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Abstentions</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom" align="center">240,655,160</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">17,590,706</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">50,902</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">0</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. The HCA Healthcare, Inc. 2023 Employee Stock Purchase Plan was approved as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:86%;border:0;margin:0 auto">


<tr>

<td style="width:24%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Abstentions</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center"><span style="white-space:nowrap">Broker&#160;Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom" align="center">238,190,613</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">3,161,931</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">453,053</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">16,491,171</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. The adoption of a <span style="white-space:nowrap">non-binding</span> advisory resolution on the Company&#8217;s named executive officer compensation as described in the Company&#8217;s 2023 proxy statement was approved as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:86%;border:0;margin:0 auto">


<tr>

<td style="width:24%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Abstentions</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom" align="center">230,579,766</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">10,927,402</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">298,429</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">16,491,171</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. The stockholder proposal regarding political spending disclosure as described in the Company&#8217;s 2023 proxy statement was not approved as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:86%;border:0;margin:0 auto">


<tr>

<td style="width:24%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Abstentions</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom" align="center">56,754,193</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">184,337,030</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">714,374</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">16,491,171</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. The stockholder proposal regarding an amendment to the Patient Safety and Quality of Care Committee charter as described in the Company&#8217;s 2023 proxy statement was not approved as follows: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:86%;border:0;margin:0 auto">


<tr>

<td style="width:24%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Abstentions</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Broker <span style="white-space:nowrap">Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom" align="center">45,502,303</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">194,874,882</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">1,428,412</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">16,491,171</td></tr>
</table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d423503dex101.htm">HCA Healthcare, Inc. 2023 Employee Stock Purchase Plan. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:7%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:92%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">HCA HEALTHCARE, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John M. Franck II</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">John M. Franck II</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Vice President &#8211; Legal and Corporate Secretary</td></tr>
</table></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: April&#160;21, 2023 </p>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d423503dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HCA HEALTHCARE, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2023 EMPLOYEE STOCK PURCHASE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INTRODUCTION
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.1</B> <B>ESTABLISHMENT OF PLAN</B>. HCA Healthcare, Inc., a Delaware corporation (the &#147;Company&#148;), adopts the following
nonqualified employee stock purchase plan for its eligible employees. This Plan shall be known as the HCA Healthcare, Inc. 2023 Employee Stock Purchase Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.2</B> <B>PURPOSE</B>.<B> </B>The purpose of this Plan is to provide an opportunity for eligible employees of the Company and certain
subsidiaries of the Company to become stockholders in the Company. It is believed that employee participation in the ownership of the business will help to achieve the unity of purpose conducive to the continued growth of the Company and to the
mutual benefit of its stockholders and the employees of the Company and certain subsidiaries of the Company. Participation in the Plan is entirely voluntary, and neither the Company nor any of its subsidiaries makes any recommendations to their
Employees as to whether they should participate in the Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.3</B> <B><FONT STYLE="white-space:nowrap">NON-QUALIFICATION.</FONT>
</B>The Plan is not intended to be an employee benefit plan under the Employee Retirement Income Security Act of 1974, as amended, nor qualify as an &#147;employee stock purchase plan&#148; under Section&nbsp;423 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1.4</B> <B>COMPLIANCE WITH SECURITIES LAWS</B>. The Plan Administrator shall have the power to make each grant of an option to purchase
Stock to Eligible Employees under the Plan subject to such conditions as it deems necessary or appropriate to comply with the then-existing requirements of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended,
including Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> (or any similar rule) promulgated by the Securities and Exchange Commission thereunder. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used herein, the following words and phrases shall have the meanings specified below: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.1</B> <B>BASE PAY</B>. The amount of base salary, wages, or basic hourly rate of compensation paid to an Eligible Employee by the Company
or a Subsidiary as compensation for services to the Company or Subsidiary before subtracting any elective deferrals to a qualified plan under Section&nbsp;401(k) of the Code, salary reduction contributions to a cafeteria plan under Section&nbsp;125
of the Code or elective deferrals to a nonqualified deferred compensation plan, including overtime and paid time off but excluding bonuses, commissions, education or tuition reimbursements, imputed income arising under any group insurance or benefit
program, travel expenses, business and relocation expenses, and income received in connection with equity-based awards. The Plan Administrator shall have the discretion to determine the application of this definition to Participant&#146;s
contributions from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.2</B> <B>BOARD OF DIRECTORS</B>. The Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.3</B> <B>CHANGE IN CONTROL</B>. Any of the following events: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the sale or disposition, in one or a series of related transactions, of all or substantially all of the assets of the Company to any
Person or Group; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) any Person or Group becomes the Beneficial Owner (as such term is defined in Rule
<FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act (or any successor rule thereto) (except that a Person shall be deemed to have &#147;beneficial ownership&#148; of all shares that any such Person has the right to acquire, whether
such right is exercisable immediately or only after the passage of time)), directly or indirectly, of more than 50% of the total voting power of the voting stock of the Company (or any entity which controls the Company), including by way of merger,
consolidation, tender or exchange offer or otherwise; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) a reorganization, recapitalization, merger or consolidation (a &#147;Corporate
Transaction&#148;) involving the Company, unless securities representing more than 50% of the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors of the Company or the corporation
resulting from such Corporate Transaction (or the parent of such corporation) are Beneficially Owned subsequent to such transaction by the Person or Persons who were the Beneficial Owners of the outstanding voting securities entitled to vote
generally in the election of directors of the Company immediately prior to such Corporate Transaction, in substantially the same proportions as their ownership immediately prior to such Corporate Transaction; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) during any period of 12 months, individuals who at the beginning of such period constituted the Board of Directors (together with any new
directors whose election by such Board of Directors or whose nomination for election by the shareholders of the Company was approved by a vote of a majority of the directors of the Company, then still in office, who were either directors at the
beginning of such period or whose election or nomination for election was previously so approved) cease for any reason to constitute a majority of the Board of Directors then in office. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.4</B> <B>CLOSING MARKET PRICE</B>. The closing price of the Stock as reported in the consolidated trading of the New York Stock Exchange
listed securities; provided that if there should be any material alteration in the present system of reporting sales prices of such Stock, or if such Stock should no longer be listed on the New York Stock Exchange, the market value of the Stock as
of a particular date shall be determined in such a method as shall be specified by the Plan Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.5</B> <B>CODE</B>. The
Internal Revenue Code of 1986, as amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.6</B> <B>COMMENCEMENT DATE</B>. The first day of each Option Period.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.7</B> <B>CONTRIBUTION ACCOUNT</B>. The account established on behalf of a Participant
to which shall be credited the amount of the Participant&#146;s contributions, pursuant to Article V. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.8</B> <B>EFFECTIVE DATE</B>.
April&nbsp;19, 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.9</B> <B>ELIGIBLE EMPLOYEE</B>. Each employee who is employed by an Employer and designated on the books and
records of such Employer as an employee, provided that the term &#147;Eligible Employee&#148; shall not include: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) an individual who
has been employed by an Employer for less than two (2)&nbsp;consecutive months; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) an individual covered by a collective bargaining
agreement, unless such agreement specifically provides for participation hereunder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) an individual who has entered into an agreement
with an Employer which excludes such individual from participation in employee benefit plans of an Employer; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) an individual who is not
classified by an Employer as an employee, even if such individual is retroactively <FONT STYLE="white-space:nowrap">re-characterized</FONT> as an employee by a third party or such Employer; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) an individual whose participation may be precluded under Company policies or guidelines or applicable laws, rules or regulations, as
determined by the Plan Administrator from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.10</B> <B>EMPLOYER</B>. The Company and any Entity (i)&nbsp;which is a
Subsidiary of the Company, (ii)&nbsp;which is authorized by the Company to adopt this Plan with respect to its Eligible Employees, and (iii)&nbsp;which adopts this Plan. The term &#147;Employer&#148; shall include any Entity into which an Employer
may be merged or consolidated or to which all or substantially all of its assets may be transferred, provided that the surviving or transferee Entity would qualify as a Subsidiary under Section&nbsp;2.23 hereof and that such Entity does not
affirmatively disavow this Plan.<B></B><B>&nbsp;</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.11</B> <B>ENTITY</B>. Any individual, corporation, partnership, limited
liability company, association, joint-stock company, trust, business trust, unincorporated organization, government or political subdivision thereof or other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.12</B> <B>EXERCISE DATE</B>. The last trading date of each Option Period on the New York Stock Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.13</B> <B>EXERCISE PRICE</B>. The price per share of the Stock to be charged to Participants at the Exercise Date, as determined in
Section&nbsp;6.3. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.14</B> <B>FIVE-PERCENT STOCKHOLDER</B>. An employee who owns five percent (5%) or more
of the total combined voting power or value of all classes of stock or equity interests of the Company or any parent or Subsidiary thereof. In determining this five percent (5%) test, shares of stock or equity interests which the employee may
purchase under outstanding options, as well as stock or equity interests attributed to the employee under Section&nbsp;424(d) of the Code, shall be treated as stock or equity interests owned by the employee in the numerator, but shares of stock or
equity interests which may be issued under options shall not be counted in the total of outstanding shares in the denominator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.15</B> <B>GRANT DATE</B>. The first trading date of each Option Period on the New York Stock Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.16</B> <B>GROUP</B>. A &#147;group,&#148; as such term is used for purposes of Section&nbsp;13(d) or 14(d) of the Securities Exchange Act
of 1934, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.17</B> <B>OPTION PERIOD</B>. Except as otherwise specified by the Plan Administrator prior to the commencement
of an Option Period, the Plan&#146;s Option Periods shall be successive periods of three (3)&nbsp;months commencing on March&nbsp;1, June&nbsp;1, September&nbsp;1, and December&nbsp;1 of each year and ending on May&nbsp;31, August&nbsp;31,
November&nbsp;30, and February&nbsp;28 (or February&nbsp;29, if a leap year) of each year; provided, however, that the first Option Period under the Plan shall not commence until the first administratively feasible date determined by the Plan
Administrator following shareholder approval of the Plan. In no event, however, may an Option Period under the Plan exceed twenty-seven (27)&nbsp;months. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.18</B> <B>PARTICIPANT</B>. Any Eligible Employee of an Employer who has met the conditions for eligibility as provided in Article IV and
who has elected to participate in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.19</B> <B>PERSON</B>. A &#147;person,&#148; as such term is used for purposes of
Section&nbsp;13(d) or 14(d) of the Securities Exchange Act of 1934, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.20</B> <B>PLAN</B>. The HCA Healthcare, Inc. 2023
Employee Stock Purchase Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.21</B> <B>PLAN ADMINISTRATOR</B>. A committee composed of one or more individuals to whom authority is
delegated by the Board of Directors or the Compensation Committee of the Board of Directors to administer the Plan. The initial Plan Administrator shall be the Compensation Committee of the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.22</B> <B>STOCK</B>. Those shares of common stock of the Company which are reserved pursuant to Section&nbsp;6.1 for issuance upon the
exercise of options granted under this Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2.23</B> <B>SUBSIDIARY</B>. Any Entity (other than the Company) of which 50% or more of
the voting power of its equity securities or equity interests are owned directly or indirectly by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCKHOLDER APPROVAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.1</B> <B>STOCKHOLDER APPROVAL REQUIRED</B>. This Plan must be approved by the stockholders of the Company within twelve (12)&nbsp;months
before or after its adoption by the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.2</B> <B>STOCKHOLDER APPROVAL FOR CERTAIN AMENDMENTS</B>. Without the
approval of the stockholders of the Company, no amendment to this Plan shall (i)&nbsp;increase the number of shares reserved under the Plan, other than as provided in Section&nbsp;10.4, or (ii)&nbsp;alter the granting corporation or the Stock
available for purchase under the Plan. Approval by stockholders must occur within one (1)&nbsp;year of such amendment (or such amendment shall be void <I>ab initio</I>), comply with applicable provisions of the corporate certificate of incorporation
and bylaws of the Company, comply with Delaware law prescribing the method and degree of stockholder approval required for issuance of corporate stock or options and comply with any other applicable law or listing standards. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELIGIBILITY
AND PARTICIPATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.1</B> <B>CONDITIONS</B>. An individual shall become eligible to become a Participant on the Commencement Date
next following the date such Participant has been employed as an Eligible Employee of an Employer. Notwithstanding anything to the contrary contained herein, no individual who is not an Eligible Employee shall be granted an option to purchase Stock
under the Plan, and no individual who is a Five-Percent Stockholder shall be eligible to participate in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.2</B>
<B>APPLICATION FOR PARTICIPATION</B>. Each Eligible Employee shall be furnished a summary of the Plan and an enrollment form. If such Eligible Employee elects to participate hereunder, the Eligible Employee shall complete such form (or <FONT
STYLE="white-space:nowrap">on-line</FONT> enrollment process as determined by the Plan Administrator) and file it with the Eligible Employee&#146;s Employer (or the third party plan administrator appointed by the Plan Administrator) no later than
fifteen (15)&nbsp;days prior to the next Commencement Date or such other date as determined by the Plan Administrator (the &#147;Enrollment Period&#148;). The duration and timing of any Enrollment Periods may be changed or modified by the Plan
Administrator from time to time. The completed enrollment form shall indicate the amount of employee contributions authorized by the Eligible Employee. If no new enrollment form is filed by a Participant in advance of any Option Period after the
initial Option Period, that Participant shall be deemed to have elected to continue to participate with the same contribution previously elected (subject to the contribution limits set forth in Section&nbsp;5.1 and Section&nbsp;5.4). If any Eligible
Employee does not elect to participate in any given Option Period, such Eligible Employee may elect to participate on any future Commencement Date so long as the Eligible Employee continues to meet the eligibility requirements and files a new
enrollment form (or completes an <FONT STYLE="white-space:nowrap">on-line</FONT> enrollment form, if permitted by the Plan Administrator) with the Employer (or third party administrator) during the applicable Enrollment Period, designating the
desired withholding rate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.3</B> <B>DATE OF PARTICIPATION</B>. All Eligible Employees who elect to participate shall be enrolled in
the Plan commencing with the first pay date after the Commencement Date following their submission of the enrollment form. Upon becoming a Participant, the Participant shall be bound by the terms of this Plan, including any amendments whenever made.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.4</B> <B>ACQUISITION OR CREATION OF SUBSIDIARY</B>. Except as otherwise provided
(i)&nbsp;in a written notice provided by the Plan Administrator prior to a Commencement Date or (ii)&nbsp;pursuant to the terms of an applicable merger, asset, stock or other similar acquisition agreement, if an Entity is acquired by the Company or
another Employer so that the acquired Entity becomes a Subsidiary, or if a Subsidiary is created, the Subsidiary in either case shall become an Employer and its Eligible Employees shall become eligible to participate in the Plan on the first
reasonably practicable Commencement Date following the acquisition or creation of the Subsidiary (taking into consideration such factors as conversion of payroll systems, assumption of other benefit plans and other administrative matters) and the
Subsidiary&#146;s adoption of the Plan. Notwithstanding the foregoing, the Company may (i)&nbsp;provide that the acquired or newly created Subsidiary shall not be a participating Employer or (ii)&nbsp;attach any condition whatsoever to eligibility
of the employees of the acquired or newly created Subsidiary, except to the extent such condition would not comply with applicable law or listing standards. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONTRIBUTION
ACCOUNT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.1</B> <B>EMPLOYEE CONTRIBUTIONS</B>. Submission of a completed enrollment form (including via electronic submission, if
permitted by the Plan Administrator) by each Participant shall authorize the Employer to deduct from the Participant&#146;s compensation an amount during each payroll period not less than <FONT STYLE="white-space:nowrap">one-percent</FONT> (1%) nor
more than fifteen percent (15%) of the Participant&#146;s Base Pay from time to time. The dollar amount deducted each payday shall be credited to the Participant&#146;s Contribution Account. Participant contributions will not be permitted to
commence at any time during the Option Period other than on the Commencement Date. Unless otherwise determined by the Plan Administrator with respect to an Option Period, no interest will accrue on any contributions or on the balance in a
Participant&#146;s Contribution Account. All Participant contributions withheld by the Company under the Plan are general corporate assets of the Company and may be used by the Company for any corporate purpose. The Company is not obligated to
segregate such Participant contributions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.2</B> <B>MODIFICATION OF CONTRIBUTION RATE</B>. No change shall be permitted in a
Participant&#146;s amount of contribution except upon a Commencement Date, and then only if the Participant files a new enrollment form (or completes an <FONT STYLE="white-space:nowrap">on-line</FONT> enrollment form, if permitted by the Plan
Administrator) with the Employer (or third party administrator) during the applicable Enrollment Period, designating the desired withholding rate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.3</B> <B>DISCONTINUATION OF CONTRIBUTIONS AND DEEMED WITHDRAWAL</B>. Notwithstanding Section&nbsp;5.2, a Participant may notify the
Employer at any time during an Option Period (except during the fifteen (15)&nbsp;day period preceding the applicable Exercise Date or such other period as determined by the Plan Administrator) that such Participant wishes to discontinue
contributions to the Plan. This notice shall be in writing and on such forms as provided by the Employer. In the event such notice is given, the Employer will cease making deductions from the Participant&#146;s compensation as soon as practicable
following the Employer&#146;s </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
receipt of the notice, the Participant will be deemed to have elected to withdraw Participant&#146;s prior contributions from the Participant&#146;s Contribution Account, and the option granted
to such Participant shall be canceled. The balance of the Participant&#146;s Contribution Account will be paid in cash to such Participant as soon as practicable following the end of the Option Period. If contributions are discontinued and withdrawn
in this manner, the Participant shall be prohibited from making further contributions during that Option Period, and the Participant shall become eligible to recommence contributions on the next Commencement Date so long as the Participant continues
to meet the eligibility requirements and files a new enrollment form (or completes an <FONT STYLE="white-space:nowrap">on-line</FONT> enrollment form, if permitted by the Plan Administrator) with the Employer (or third party administrator) during
the applicable Enrollment Period, designating the desired withholding rate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5.4</B> <B>LIMITATIONS ON CONTRIBUTIONS</B>. During each
Option Period, the total contributions by a Participant to Participant&#146;s Contribution Account shall not exceed fifteen percent (15%) of the Participant&#146;s Base Pay for the Option Period. In addition, no Participant shall be permitted to
contribute more than twenty five thousand dollars ($25,000.00) to such Participant&#146;s Contribution Account in any calendar year (determined on the Grant Date(s)). The foregoing limitation shall be applied taking options into account in the order
in which such options were granted. If a Participant&#146;s total contributions should exceed either limit, the excess shall be returned to the Participant after the end of the Option Period, without interest. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ISSUANCE
AND EXERCISE OF OPTIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.1</B> <B>RESERVED SHARES OF STOCK</B>. The Company shall initially reserve 10&nbsp;million (10,000,000)
shares of Stock for issuance upon exercise of the options granted under this Plan (the &#147;Share Reserve&#148;). If any option granted under the Plan shall for any reason terminate without having been exercised, the unpurchased Stock underlying
such option shall again become available for issuance under the Plan. In the event shares of Stock are withheld for the satisfaction of Withholding Taxes in accordance with Section&nbsp;6.7, such shares of Stock shall again become available for
issuance under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.2</B> <B>ISSUANCE OF OPTIONS</B>. On the Grant Date each Participant shall be deemed to receive an option
to purchase Stock with the number of shares and Exercise Price determined as provided in this Article VI, subject to the contribution limits specified in Section&nbsp;5.1 and Section&nbsp;5.4. All such options shall be automatically exercised on the
following Exercise Date, except for options which are canceled when a Participant discontinues the Participant&#146;s contributions and withdraws the balance of the Participant&#146;s Contribution Account pursuant to Section&nbsp;5.3 or which are
otherwise terminated under the provisions of this Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.3</B> <B>DETERMINATION OF EXERCISE PRICE</B>. Unless otherwise established
by the Plan Administrator prior to the start of an Option Period, the Exercise Price of the options granted under this Plan for any Option Period shall be ninety percent (90%) of the Closing Market Price of the Stock on the Exercise Date. In no
event, however, may the Exercise Price of the options granted under the Plan be less than eighty percent (80%) of the Closing Market Price of the Stock on the Exercise Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.4</B> <B>PURCHASE OF STOCK</B>. On an Exercise Date, all options shall be automatically
exercised, except that the options of a Participant who has terminated employment pursuant to Article VII or whose contributions have been discontinued and withdrawn pursuant to Section&nbsp;5.3 shall expire and not be exercised. The Contribution
Account of each Participant shall be used to purchase the maximum number of shares (including fractional shares, unless otherwise provided by the Plan Administrator) of Stock determined by dividing the Exercise Price into the balance of the
Participant&#146;s Contribution Account. Any money remaining in a Participant&#146;s Contribution Account shall be used in the next Option Period along with new contributions in the next Option Period; provided, however, that if the Participant does
not enroll for the next Option Period, the balance remaining shall be returned to the Participant in cash, without interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.5</B>
<B>TERMS OF OPTIONS</B>. Options granted under this Plan shall be subject to such amendment or modification as the Company shall deem necessary to comply with any applicable law or regulation, including any applicable tax withholding obligations,
and shall contain such other provisions as the Company shall from time to time deem necessary and approve. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.6</B> <B>LIMITATIONS ON
OPTIONS</B>. The options granted hereunder are subject to the following limitations: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) No option may be granted to a Participant if the
Participant immediately after the option is granted would be a Five-Percent Stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) No Participant may assign, transfer or
otherwise alienate any options granted to the Participant under this Plan, otherwise than by will or the laws of descent and distribution, and such options must be exercised during the Participant&#146;s lifetime only by the Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.7</B> <B>WITHHOLDING OF TAXES</B>. Upon each Exercise Date, the Company shall have the right and is hereby authorized to satisfy any
applicable withholding obligations or withholding taxes (&#147;Withholding Taxes&#148;), including any federal Withholding Taxes as set forth by Internal Revenue Service guidelines for the Employer&#146;s minimum statutory withholding, with respect
to the Participant&#146;s purchase of Stock.<B> </B>The Company may satisfy Withholding Taxes (i)&nbsp;by withholding cash from the Participant&#146;s Contribution Account or the Participant&#146;s compensation, and/or (ii)&nbsp;by withholding from
the Stock otherwise purchased on the Exercise Date that number of shares of Stock (including fractional shares, unless otherwise provided by the Plan Administrator) necessary to satisfy the Withholding Taxes with respect to such Stock based on the
Closing Market Price of the Stock as of the Exercise Date. The Plan Administrator shall communicate the manner of such withholding to the Participants prior to the applicable Commencement Date. The Company&#146;s obligation to make any delivery or
transfer of Stock shall be conditioned on the Participant&#146;s compliance, to the Company&#146;s satisfaction, with any withholding requirement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.8</B> <B><FONT STYLE="white-space:nowrap">PRO-RATA</FONT> REDUCTION OF OPTIONED STOCK</B>. If the total number of shares of Stock to be
purchased under options by all Participants on an Exercise Date exceeds the number of shares of Stock remaining authorized for issuance under Section&nbsp;6.1, a <FONT STYLE="white-space:nowrap">pro-rata</FONT> allocation of the shares of Stock
available for issuance will be made among Participants in proportion to their respective Contribution Account balances on the Exercise Date, and any money remaining in the Contribution Accounts shall be returned to the Participants, without
interest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.9</B> <B>STATE SECURITIES LAWS</B>. Notwithstanding anything to the contrary contained
herein, the Company shall not be obligated to issue shares of Stock to any Participant if to do so would violate any State (or other applicable) securities law applicable to the sale of Stock to such Participant. In the event that the Company
refrains from issuing shares of Stock to any Participant in reliance on this Section, the Company shall return to such Participant the amount in such Participant&#146;s Contribution Account that would otherwise have been applied to the purchase of
Stock, without interest. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERMINATION OF PARTICIPATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any Participant whose employment with an Employer is terminated during the Option Period prior to the Exercise Date for any reason shall cease
being a Participant immediately. A Participant will not be deemed to have terminated employment for this purpose if the Participant is on an approved leave of absence for military service or sickness or for any other purpose approved by the Company,
if the Participant&#146;s right to reemployment is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Plan Administrator otherwise provides in writing. The balance of that
Participant&#146;s Contribution Account shall be paid in cash to such Participant (or, following the Participant&#146;s death, to the Participant&#146;s legal representative) as soon as practical after such Participant&#146;s termination of
employment; provided however, the Participant&#146;s Contribution Account may still be maintained on behalf of such Participant, however, the Participant&#146;s Contribution Account will cease to be administered under or have any other affiliation
with the Plan. The option granted to such Participant shall expire and thereafter be null and void. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OWNERSHIP OF STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.1</B> <B>ISSUANCE OF STOCK</B>. As soon as practical after the Exercise Date, the Plan Administrator will, in its sole discretion, either
credit a share account maintained for the benefit of each Participant, make such other book entry registration, or issue certificates to each Participant for the number of shares of Stock purchased under the Plan by such Participant during an Option
Period (less any shares of Stock withheld pursuant to Section&nbsp;6.7). Such determination by the Plan Administrator shall apply equally to all shares of Stock purchased during the Option Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.2</B> <B>RESTRICTIONS ON SALE</B>. Shares of Stock purchased pursuant to Article VI of the Plan will be subject to Company&#146;s
security trading policies, as may be in place from time to time. In addition, the Plan Administrator may, in its discretion, require as conditions to the Participant&#146;s purchase of shares of Stock under the Plan (i)&nbsp;such conditions as it
may deem necessary to assure that such sale of shares of Stock is in compliance with applicable securities laws and (ii)&nbsp;a minimum holding period (not to exceed one year) following the purchase of shares of Stock before such shares may be sold
or otherwise transferred, provided that such holding period, if any, shall not apply to shares of Stock withheld for the satisfaction of Withholding Taxes in accordance with Section&nbsp;6.7. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.3</B> <B>TRANSFER OF OWNERSHIP</B>. A Participant will have no voting rights or any
other interest in shares to be purchased pursuant to Article VI of the Plan until such shares have been issued pursuant to Section&nbsp;8.1. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.4</B> <B>AUTOMATIC DIVIDEND REINVESTMENT</B>. Each Participant&#146;s Contribution Account shall be established with the following default
dividend policy. Cash dividends, if any, paid with respect to the Stock held in each Participant&#146;s Contribution Account under the Plan shall be automatically reinvested in Stock, unless the Participant directs otherwise. Any and all cash
dividends paid on shares of Stock held in a Participant&#146;s Contribution Account shall be credited to the Participant&#146;s Contribution Account on the basis of the number of shares in the Participant&#146;s Contribution Account on the date of
record of the dividend and shall be reinvested to acquire shares of Stock purchased in the open market by the plan administration agent or custodian, as applicable. Purchases of Stock under this Section&nbsp;8.4 will be made as promptly as
practicable (but not more than 30 days) after a dividend payment date. All shares of Stock acquired under this Section&nbsp;8.4 will be held in the Plan in the same name as the Stock upon which the cash dividends were paid. The Plan Administrator
shall have the right at any time or from time to time upon written notice to the plan administration agent or custodian, as applicable, to change the default dividend reinvestment policy for the Participant Contribution Accounts established under
the Plan. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADMINISTRATION AND AMENDMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.1</B> <B>ADMINISTRATION</B>. The Plan Administrator shall (i)&nbsp;administer the Plan, (ii)&nbsp;keep records of the Contribution
Account balance of each Participant, (iii)&nbsp;interpret the Plan, (iv)&nbsp;determine all questions arising as to eligibility to participate, amount of contributions permitted, determination of the Exercise Price, terms and conditions of the Plan
(which terms and conditions may differ among individual options and Participants) and all other matters of administration, (v)&nbsp;determine whether to place restrictions on the sale and transfer of Stock and the nature of such restrictions, as
provided in Section&nbsp;8.2, (vi) adopt such rules, <FONT STYLE="white-space:nowrap">sub-plans,</FONT> guidelines or offerings as may be deemed necessary or appropriate to comply with the laws of other countries, allow for the <FONT
STYLE="white-space:nowrap">tax-preferred</FONT> treatment of the options or otherwise provide for the participation by employees who reside outside of the U.S., including determining which employees are eligible to participate in the Plan, provided
however, the adoption of a <FONT STYLE="white-space:nowrap">sub-plan</FONT> shall not increase the Share Reserve in Section&nbsp;6.1 above, (vii)&nbsp;establish the exchange ratio applicable to amounts withheld in a currency other than U.S. dollars,
and (viii)&nbsp;permit payroll withholding in excess of the amount designated by a Participant in order to adjust for delays or mistakes in the processing of properly completed enrollment forms. The Plan Administrator shall have such duties, powers
and discretionary authority as may be necessary to discharge the foregoing duties, and may delegate any or all of the foregoing duties to any individual or individuals (including officers or other employees who are Participants). The Board of
Directors or the Compensation Committee of the Board of Directors shall have the right at any time and without notice to remove or replace any individual or committee of individuals serving as Plan Administrator. All determinations by the Plan
Administrator shall be conclusive and binding on all persons. Any rules, regulations, or procedures that may be necessary for the proper administration or functioning of this Plan that are not covered in this Plan document shall be promulgated and
adopted by the Plan Administrator. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.2</B> <B>AMENDMENT</B>. The Board of Directors or the Compensation Committee of the
Board of Directors may at any time amend the Plan in any respect, including termination of the Plan, without notice to Participants. If the Plan is terminated, all options outstanding at the time of termination shall become null and void and the
balance in each Participant&#146;s Contribution Account shall be paid to that Participant, without interest. Notwithstanding the foregoing, no amendment of the Plan as described in Section&nbsp;3.2, or as may be required to otherwise comply with any
applicable tax or regulatory requirement, shall become effective until and unless such amendment is approved by the stockholders of the Company in accordance with the approval requirements of Section&nbsp;3.2. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE X. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.1</B>
<B>PLAN TERM</B>. The Plan shall continue in effect for a term of ten (10)&nbsp;years from the Effective Date unless sooner terminated under Section&nbsp;9.2 hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.2</B> <B>EXPENSES</B>. The Company will pay all expenses of administering this Plan that may arise in connection with the Plan,
excluding individual federal, state, city, local or other taxes and any expenses that arise in connection with actions initiated by a Participant. For the avoidance of doubt, the Company will not pay, or cause to be paid, any fees or commissions
associated with the sale of shares, transfer of shares, wire transfers, overnight mailing fees or other similar administrative/regulatory fees. As of the date of a Participant&#146;s employment or service relationship ceases (the &#147;Termination
Date&#148;), the Participant shall pay for any and all expenses and costs related to such Participant&#146;s Contribution Account, including but not limited to brokerage commissions on purchases of shares made on or after the Termination Date and
any other fees, commissions or charges for which the Participant would otherwise have been responsible for had such Participant continued to be a Participant in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.3</B> <B>NO CONTRACT OF EMPLOYMENT</B>. Nothing in this Plan shall be construed to constitute a contract of employment between an
Employer and any individual or to be an inducement for the employment of any individual. Nothing contained in this Plan shall be deemed to give any individual the right to be retained in the service of an Employer or to interfere with the right of
an Employer to discharge any individual at any time, with or without cause, regardless of the effect which such discharge may have upon the individual as a Participant of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.4</B> <B>ADJUSTMENT UPON CHANGES IN STOCK</B>. The aggregate number of shares and class of shares of Stock reserved for purchase under
the Plan as provided in Section&nbsp;6.1, and the calculation of the Exercise Price as provided in Section&nbsp;6.3, shall be adjusted by the Plan Administrator (subject to direction by the Board of Directors or the Compensation Committee of the
Board of Directors) in an equitable and proportionate manner to reflect changes in the capitalization of the Company, including, but not limited to, such changes as result from merger, consolidation, reorganization, recapitalization, stock dividend,
dividend in property other than cash, stock split, combination of shares, exchange of shares and change in corporate structure. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.5</B> <B>CHANGE IN CONTROL</B>. In the event of a proposed Change in Control of the
Company, the Plan Administrator, in its discretion, may terminate the Plan in accordance with Section&nbsp;9.2 or may shorten the Option Period then in progress by setting a new Exercise Date (the &#147;New Exercise Date&#148;), which New Exercise
Date shall be a date before the date of the proposed Change in Control. If a New Exercise Date is set, the Plan Administrator shall notify each Participant in writing, prior to the New Exercise Date, that the Exercise Date for the Option Period has
been changed to the New Exercise Date and that the Participant&#146;s option shall be exercised automatically on the New Exercise Date unless the Participant has discontinued contributions and withdrawn the balance of the Participant&#146;s
Contribution Account in accordance with Section&nbsp;5.3 by a time specified in such notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.6</B> <B>SECTION 409A</B>. The Plan is
intended to be exempt from the application of Section&nbsp;409A of the Code (&#147;Section&nbsp;409A&#148;) under the short-term deferral exception and any ambiguities shall be construed and interpreted in accordance with such intent. In furtherance
of the foregoing and notwithstanding any provision in the Plan to the contrary, if the Plan Administrator determines that an option granted under the Plan may be subject to Section&nbsp;409A or that any provision in the Plan would cause an option
under the Plan to be subject to Section&nbsp;409A, the Plan Administrator may amend the terms of the Plan and/or of an outstanding option granted under the Plan, or take such other action the Plan Administrator determines is necessary or
appropriate, in each case, without the Participant&#146;s consent, to exempt any outstanding option or future option that may be granted under the Plan from or to allow any such options to comply with Section&nbsp;409A, but only to the extent any
such amendments or action by the Plan Administrator would not violate Section&nbsp;409A. Notwithstanding the foregoing, the Company shall have no liability to a participant or any other party if the option under the Plan that is intended to be
exempt from or compliant with Section&nbsp;409A is not so exempt or compliant or for any action taken by the Plan Administrator with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.7</B> <B>EMPLOYER&#146;S RIGHTS</B>. The rights and powers of any Employer shall not be affected in any way by its participation in this
Plan, including but not limited to the right or power of any Employer to make adjustments, reclassifications, reorganizations or changes of its capital or business structure or to merge or to consolidate or to dissolve, liquidate or sell, or
transfer all or any part of its business or assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.8</B> <B>LIMIT ON LIABILITY</B>. No liability whatsoever shall attach to or be
incurred by any past, present or future stockholders, officers or directors, as such, of the Company or any Employer, under or by reason of any of the terms, conditions or agreements contained in this Plan or implied therefrom, and any and all
liabilities of any and all rights and claims against the Company, an Employer, or any stockholder, officer or director as such, whether arising at common law or in equity or created by statute or constitution or otherwise, pertaining to this Plan,
are hereby expressly waived and released by every Participant as a part of the consideration for any benefits under this Plan; provided, however, no waiver shall occur, solely by reason of this Section&nbsp;10.8, of any right which is not
susceptible to advance waiver under applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.9</B> <B>GOVERNING LAW</B>. The validity, construction, interpretation, administration
and effect of this Plan, and any rules or regulations promulgated hereunder, including all rights or privileges of any Participants hereunder, shall be governed exclusively by and in accordance with the laws of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.10</B> <B>HEADINGS</B>. Any headings or subheadings in this Plan are inserted for convenience of reference only and are to be ignored in
the construction of any provisions hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10.11</B> <B>SEVERABILITY</B>. If any provision of this Plan is held by a court to be
unenforceable or is deemed invalid for any reason, then such provision shall be deemed inapplicable and omitted, but all other provisions of this Plan shall be deemed valid and enforceable to the full extent possible under applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>hca-20230419.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 4/21/2023 6:34:50 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:hca="http://www.hcahealthcare.com/20230419"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.hcahealthcare.com/20230419"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hca-20230419_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hca-20230419_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>hca-20230419_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 4/21/2023 6:34:50 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>hca-20230419_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 4/21/2023 6:34:50 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="hca-20230419.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139627370541552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Apr. 19, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000860730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 19,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HCA HEALTHCARE, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-11239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-3865930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Park Plaza<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Nashville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(615)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">344-9551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $.01 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HCA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d423503d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hca-20230419.xsd" xlink:type="simple"/>
    <context id="duration_2023-04-19_to_2023-04-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000860730</identifier>
        </entity>
        <period>
            <startDate>2023-04-19</startDate>
            <endDate>2023-04-19</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2023-04-19_to_2023-04-19">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-04-19_to_2023-04-19"
      id="Hidden_dei_EntityCentralIndexKey">0000860730</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-04-19_to_2023-04-19">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-04-19_to_2023-04-19">2023-04-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2023-04-19_to_2023-04-19">HCA HEALTHCARE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-04-19_to_2023-04-19">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-04-19_to_2023-04-19">001-11239</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-04-19_to_2023-04-19">27-3865930</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-04-19_to_2023-04-19">One Park Plaza</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-04-19_to_2023-04-19">Nashville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-04-19_to_2023-04-19">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-04-19_to_2023-04-19">37203</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-04-19_to_2023-04-19">(615)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-04-19_to_2023-04-19">344-9551</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-04-19_to_2023-04-19">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-04-19_to_2023-04-19">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-04-19_to_2023-04-19">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-04-19_to_2023-04-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-04-19_to_2023-04-19">Common Stock, $.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-04-19_to_2023-04-19">HCA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-04-19_to_2023-04-19">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-04-19_to_2023-04-19">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" "]@Y56N+5.$TH$  "&$   &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V8;W/B-A#&OXK&O>FT,TELF?\I,$,(:9C+<4R@O6D[?2%L@36Q+9\D(.FG
MOY4A-KTS:_(B6,;[^*?5ZI%$?R_5BXXX-^0UB5,]<")CLEO7U4'$$Z9O9,93
M^&8M5<(,--7&U9GB+,R#DMCU/:_M)DRDSK"?WYNK85]N32Q2/E=$;Y.$J;<[
M'LO]P*'.^XUGL8F,O>$.^QG;\ 4W?V1S!2VW4 E%PE,M9$H47P^<$;V]\YLV
M('_B3\'W^N2:V*ZLI'RQC6DX<#Q+Q&,>&"O!X&/'QSR.K1)P?#V*.L4[;>#I
M];OZ0]YYZ,R*:3Z6\1<1FFC@=!T2\C7;QN99[A_YL4,MJQ?(6.?_R?[P;--S
M2+#51B;'8"!(1'KX9*_'1)P$-'IG OQC@)]S'UZ44]XSPX9])?=$V:=!S5[D
M7<VC 4ZD=E061L&W N+,\%X&6TBR(2P-R20UPKR1:7H8;<A:WS7P$ONH&QP%
M[PZ"_AG!4:9N".U=$=_S&_\/=X&M /0+0#_7:YS1&\L=5^2?T4H;!4/X;Q71
M0:%9K6#K^E9G+. #!PI7<[7CSO#GGVC;^PWA:Q1\#4Q].(+LA7D&'V*VJ:+#
MX]<LUASA:!8<353G.'9C(%$LAC$,^2OYR-^JB' E#_ZZ;:_3\!"L5H'50L6*
M^EJ^9;R*!0_O7G]$(-H%1/LRB#E70MHZ#PG,EDH>7*FH[KKR[A1HG4N&[9EO
MA"UP8)RQI!(,UWD<C\CC9/2TA(OGR169SL8W"%ZWP.M>@C=- ZDRJ7)/( L#
MN2-CN852@XJ3824O+GP_0>AZ!5WO$KH'$7,RVR8KKJI < W/H]>4^HT>PD.]
MTDV]2XB6[)5,0Z@XL1;!(6GG^6HD_<YUH]MN]=#I2$_\GEY". I#\$)]]7Y!
MGN Y\CFM',H:28@B<Z9>R#QF_S&,LC1]BGKV#Y1CVY**+.6^>DW"Y69,1SL1
MQYC1TM+Q*6[9W\,=Y@/0S97<B32HSB&NN9QA:.4B0"]:!0JTN=0&5H._179V
MGM8H-CJ^AQD=+5<"BGMY/H8CV#J>1\$%?FG3UJ\82KD>4-S&GV0 69E',L6,
MHT:DT6Q>]UHMBA&5RP#%_?N+$L;P%%*3)-OT:!JZD@H7JMM/T-+Z*6[1"QF+
M0!B1;L@G*' E6%S)@ZO4\I1F3W&GGBN>IX?###ML*6#G!7O#S^OUF?'#]>K(
M_-+U?=RB?R";:KT%LCK &ME:P-+T?=RA%SS8*CO]J+\B2V&^-\(C#BYB>YBO
M_C)XN2(?;CQ*,J;(CL5;3C+HIXZ80GE/]ORX7R\5"VW=+=Z2E:RLNAH!V 5A
M(*75^[@M%XF;O 812S?\[/:L1FCVUP+;\?BEP_L7.?PDX6IC4_0[*)C(EE_&
MTLK=?HW@V2IS3TZ5]H3^B=DW:A+S-0AY-QUP:W4X]!X:1F;Y07,E#1Q;\\N(
M,Y@!]@'X?BVE>6_8LVOQT\/P&U!+ P04    " "]@Y56GZ ;\+$"  #B#
M#0   'AL+W-T>6QE<RYX;6S=5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^5
M6'8$>O%DN7/ZZZ>S;"=I=67=A['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0
MHW/-^R1I#T>N6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<
M2PZFTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ
M?$,78&F? KP(&K <XRBAC05C$C*$[_VX_!DP::U7A90SP24-AF+=,.>XU7=>
M&18/QA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3
M .B<45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*
MQ+^,%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*
M6BL>]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0
M\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1
M.XJRY/K%.?7A'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMH
MD<VWL,\E=,E[7FY'U=;[021>\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^
MI_VLT/T$#..VBB(KU&>%^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E
M\!>/AG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!
M#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
M   ( +V#E58<.&7J/P$  #P"   /    >&PO=V]R:V)O;VLN>&ULC5'+;L)
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MPNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " "]@Y56!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M +V#E5;;42-2[P   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( +V#E5:97)PC$ 8  )PG   3
M  "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ O8.55KBU
M3A-*!   AA   !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( +V#E5:?H!OPL0(  .(,   -
M  "  8X,  !X;"]S='EL97,N>&UL4$L! A0#%     @ O8.55I>*NQS
M$P(   L              ( !:@\  %]R96QS+RYR96QS4$L! A0#%     @
MO8.55APX9>H_ 0  / (   \              ( !4Q   'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( +V#E58D'INBK0   /@!   :              "
M ;\1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( +V#
ME59ED'F2&0$  ,\#   3              "  :02  !;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@     )  D /@(  .X3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d423503d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d423503d8k.htm">d423503d8k.htm</File>
    <File>d423503dex101.htm</File>
    <File>hca-20230419.xsd</File>
    <File>hca-20230419_lab.xml</File>
    <File>hca-20230419_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d423503d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d423503d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hca-20230419_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hca-20230419_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hca-20230419.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "hca",
   "nsuri": "http://www.hcahealthcare.com/20230419",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d423503d8k.htm",
      "contextRef": "duration_2023-04-19_to_2023-04-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d423503d8k.htm",
      "contextRef": "duration_2023-04-19_to_2023-04-19",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hcahealthcare.com//20230419/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001193125-23-110578-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-110578-xbrl.zip
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M+_:RQ(M18,_WW1Z%,0V! Y'*C9II'LVKX%5&?]8;)M,C2EZLGV=6AA5.8GH
M ;($(<&(BQ&R+C!_=P1,8NJ5F(V1?V\ UD!&!\IN62$YT&JD?=8ENJ&6(.$F
M'FO.MFNQ[0VH:@L([MU]!3T'RL[]CGEV0@PH.J+&/,.N5/J:28N:GNC]"6]W
M'B-S/\79*TO33;44E7B805JY$&Q3"*XY0[V-JX_EFC$TS_RJW]\<)7\@85C)
MF4"UHI4A6\+QJS3^&@)D%_6#WN%V12@J,Q>B5Q*B<R%&C.>B],:B9+"B>6!M
M5Y3B,M<6I:W[:!F4&#E#C(,[E:4.I$"214*IH> G'A)T=[FOLP?3'/G*FU>,
MUZX1W5C2VP6R\Z;3?[>XY2]:,VL-B.52(5YK8O:Y1'QKBG&*PGO<XZ1\<C,>
M0KH#\6JSV:] M%W$/"_CM:&2RUAL8MY\[MOW" @DM&AB+::-UKN=F%WJMD<6
M<*SI/2G9&T?S$:H!66Y"W_JFD/\IJ1H)*"?WU!TQ$N#FR,'"]7IO-+NTC ZQ
MD$;B^9QUU^^^A\E()WCM.0O,YZ T2F8RKXP<_!^??XMX(<6%"PGS:@COW+,1
M]3+2&Q-+1N2'N#K@8<#D$K29,+@C",!60,Y8Z1VYX_Y#.$#P'&!HG IBL[[C
M14O3HZ"C6DGPX$S$$=YJ#<-($3&.<NU(QA_5RB%.XZP)O/5>,8T!S5<UA;ZC
M.LWU47C<*,3B6,UAZ57FX HGG<44CB0AEH>GI_N3$GZ1!;2C_*_F&>Z6.N?]
M)[@0YXX7LK0S-ZDS (9E+C@PP+">+]V9D6 R%= HGCK"<R<<.8D3;01'FLBZ
MW#%6_N! U<C\'K0/OG!V[PC(!V) /0OCFM2R<,4W)L83*&S*;1%-&ME/^E+&
M 4U]J2P7E[)<D([ ]B8Q/]H6\F@F,Y[/_/$'L" +.9,-YQ@37V4@2H_!T -$
M<1_H6!2B?4)X]D<*9\#%]'GSIX;\=Y1T*'B<"B25XT8\/5>\W7,!?OQA+E3V
M^:I[VND6VU<7%ZWKFTXS^?&^0V6:MC!61N1/8*3Y(-#\"IGSD TC[JB45+VT
M8#E/MK2W"FT]A;:C;IXRP)'AB$LWX-3AH#Q\+E 'M:&M%"SPE5RQQ,41Z;B1
M:IE*>H1K.'S'"S$0AE_F\Z'=8)Z@D'Q,6IRC#L+48E'R$MDD0%5=8@ED/T&%
M0RT8&=W,,MR"KOSL@X:=ILD!ZE!<;:2K1_*S_*T=2?TJ]P2FYS0IY-RS2E,Y
MVHGQC?,$J..C901RY<(]LQ4B1KW_0FURJ0'"NP&,&:X8D FHJT@UOK JN64V
M7KW,8FQX/>*@\,$67;O RMG&K$R=-+,$ML("\42[ XV*3)\8N3!V?>X/Y8M,
MS^0ZK);GC<!B?65,FBL@SLVD+X(,F N$];)[?I--MN0 ;"G8T CZH8@1D*Y:
MO.9!65B;R):=4%*F7-E)Z!Q 3> ^%]?TC(; 1^G*C'1"$?X,1?)V-96A!8RB
M 'E2Z0O KI+HFG9$3",I9[83IPAX';E \)K[CV,BEZ=&$@5>'^ /&V&L9K:4
MV#5^ $KU9<,E=IC!JP 0)M9^LM$ "_M*H;DQV=6$[!G6F*D_801%EBF7PR3;
M-Z!N /<,1@H@4GH>4(G<#FB8DA-S12M= #+YR \V$Q9W@NP2F=5DM7V)K0#G
MR"WEP(H]%N$G!A -*P%1('\!WZ6;6J%@AQ-<1<]9.)YJ8\+*_9'K2E6Q=D.
M#%!M(-DD&@AT9L*0XA!%Q3HB7A2&GDSG<>#TG)!H@/W7I^!R(%9_Z>16;K&E
MQ:[MK\6^&?52<>Z#.(<A:CY@/4K^[4<'+21!"/(ETHOOQ*;&6B^R +CG?(6E
MR*JEZ:03R[O8CH!$47+O +"!/,.X^,@-A2PNN'?W#B4/K&=1$8(9"*.YIJDZ
M4-1#/X07T"Z]4E?T1E6I5>M1J$TL4^56%*D34:3.'TG=DBVI5E/TBJE4&EJF
MI&PNS"1]/+EP&72&/++,C?3+/0XQ%9/%A6B="9Y?(5W*1=UX +6"*@FJ0K]
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MU^U\VN2Y>W^=QUENAM(X770*^4<*GU=@.")BDN4&6"'TT<%\']G2+SAC7_\
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M'R3BL2LXZ=A$?/O_Z(_/!I-^Q3V&HZPTD-!"V#9U-_D>6&5GPSNM#:\"E#%
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MSD/:<,ALU3C ;G'*G=WM.)F\QSNOF MH*DB =\,YJ)-=@9;/+6@Y[D_ZX]_
MKYJ\[<&_*?;EYL!8Q$*S66(I7B/DX>#X2,C;8"I0D>SC(]R#^'_[W8[-G^'T
MK'KFBYOT8HV<UL07EQ,TH9(;8^Z(X0,)J<,WEIJ30JM5?6FK:WX*"C#8>E0H
MGDB*TE%1P9M4L_\6,C9J(KFCP\K9N!IOQ9IN)E3E,9_MA%28S[X/59E*'+O!
MM[3:13>H6$:FF/?OSM$WC3YR%CXJG7Q!+=)I7,E/^E%(+-4&[QL'Z*VV@>Q$
MR U>I3>BL_58OD=5E=X&EGL.@%S;8ZF@9)/Y7%!KYM18]WQ'F@C])=6/<4Z9
M"M^>Y-X4XAR$P4.H4"9U_:%4*(91O</&GEX;6)*HE J#9A,$.FG-FOB52C:"
ME2P=3KG-D]/>"9$T*G:+8_?7#.'&LJ6><U!X:/(C_9W6K+UGAZ=<4EP&T.U8
MW-RH#5?+5%,#=IFW]]R!VOK@CK\;# W0UE38J!89<(K1=CL/K(< /\GUK8P-
M%FQE!SQ0^6N%[<-R1E93V$+EG35:?SJR1NN9E#1_Q\6Y+^N5S<7 \\184O6[
MG:9<_<>/0Z8-RXF;6)C">U:<3K_X#)W^5@&M'[\#6I]SVQN/T]RU[MMW(PK>
M5BN0857"K:> S51>6(*#IFWHGU9+59OJ#HZZ9$X%<^2;"D\/!O8>!U_C$PA'
M9ED[2K1=F_/0U,=UG"M)U*"XJQF:-G]MLV#(RSFA"Y0T6@H4%G0M IR65?0Q
M7FU6=7/ "?@O<S;<(GV!DRGZ6V>=;8-8C,7F!Q H"<5 X+[>(F>T?G ^)A"+
MA)XL56A-K[A\,=F:C\0@]/S%#E)68:H31D;V%2);OERT_JR]C$Q#J!#9WW@E
M?2DPES&OZ^\-O5FS0W^0+RV(:IO#_-7-A&<FL0>MA$G=7K[G>'8J&/GW*-M4
M2Y-L,3<!&S=\SF] 6]NY9+ERJS)%X6OD*%N*MT8)ML^6T4</#93X.]5WXZ1,
MG064RJWM-BQG#;K&/M<8)=514"(39TGO:'F?-P.0W8ZWR-,&^\4D3Y'Q7O%!
MK =@T:]B-W7CAYEVNH6BH0= Y%IOZ]7UFW?ME(6YY(6QG8U;<Q]-:QK?GU[A
M3ZHO/\QJL6XL)7Z5AJ9,,-%V[7$"!HHBQ,-")H4[:56-5=GQH7,RD3&+5^K%
M7.L8?ZH3G!>JH!DBM!8/*E'8'%?Q'$]=4,!ZFDZTO>$L2>*EXNN!4UOJPWEN
M-^R&Y_:^#V0L8%D O&T)%.JT]X^^[#1*B" [HF*"U;6+N=R7;V4D>G-!VQ)A
M?YLTA@J7(* [OIO3T7TM>B\04I?^JB24:(\1MAI\)"A;5<4NU8+(4W6X*7)3
MLZ"OM5N )GPYMEMR79^VU3 ]&CEH0X%K68(]FM^Y'0\]:AI!,BT28^PR;2=A
MU6K"8EV\$S>/GLKZL QM>>9U@@.DCXWPZMUR#[F!-LL/'I>YTCHVS($R<0ZM
MV6BPRB:'D0VAFFEJ[,@O8*-ZI[N>9WRX/M=5RJ%S4=<L<J&H^[WER-#Y*@[S
MM!G1,#G!JTUJLS@YZ&Q*2WB[IR9UE2199T,V<#(= =028+<JY?=%'UA7XUX!
M&Y;3,*QR][':F5-#SRY]BY@E,9JP8>62>OV$"RR'U@[S0JLV +TKI6L*$-X;
MSKX<CP[&O6E/Q[/'_?/W9QH48WL(HR+65QZX59';MPJ52[#UA*NU<V=<]=^3
MCZSNA4NHKFA&D$UCUMUPCH"&B$*U !F2XNZ=(=C%![ +(G,52&)NL]<U:OSN
M5 NZF$YH%@GFX2&_$_KK34"<.A>"BOS%N=[R"+4W:DUQNHI&E1::FRL:G-+R
MNOF5#PN!%L9?PTBMY[!]@Y#;B^^0V^?40*:NYV2*J;R3_MG[\6 ZZ$^"B][O
MDV;.ZOW52[H=7;ZD;AH*;N52R;EN=Y-NHFO2*VY0%BPRY!ZQ6W,39XEV""8E
M_FO/9 [:PVO?+<J''KCK9$L @"ZF=]JNTC$J\4V#(,KPD*('UD:L*7,X)J>:
M^-91I7C7?<Q E@311 <VS2#O]49>&QW9*TW1>!2AA,;#<VI-(XM;&E8(SY9C
ME'8[<B_I8U"A+\^BV%F=O$K$JKFHTE>U-7H5>9.;ABV:7;N]+/9P[];$'<]4
M]"V""E=!+%/D2V/!O%I&O0MF8+W9&J=5U$:%U]H,SK-#%A<ZEZ4),XVU(6,J
M 28*WXAQ@%E!7$A\S0K)BI2Y*7X?6MGQ_ /=DI/E9I@"NDE[U>J"NE@:',"M
M 5[VE"E>[PP%89Q-1 "'I4(1=8Z]2NK03-*4HCGY9DY4%^\(N_,""_9&B=IX
M\5IIC:5PFG-+X+3F.A4.\;Z!P!N5#P;F'7;=?1S>/;PGPF?L-C2R4%%Y'3:8
M10:045=4<DYN8Z9\XOTF@G B(%N;5M6RR!9GMV-7T;DJVL'R'^YODV]?&JLT
MUC7"O(M6J]T*/ZTM)Z^![P.R996M=Y#S[G-J["V7L%&D6*#ADM@2S!5V4SL3
MW EPX8L53SG&RC=(YDD75/-PQR?+SHZ6T>_#_GCR=G!I J,[*\#ZPI+R7+Z2
MXX'VVK=0@_O3HFI0'!&]H^H(198PS1XL(+*-6!]V.YS;BDJ1*':1V3=FJVB,
M3M<3:(B(AHQ6.#$4O,86;RS+\1B[DFH#V*YXBU[53$I/JD59322NU2FNNMZ6
M=7%7WR353"_0JY+J19B6V(C>^PWG;DN)[Q_W,><;VM(1V,BM7=L*-*%->(<%
MKHEKA89MDFP97YL9L1OTY84EW(W[D^EX<&88[I/>A5"+)JV#:28 >*4 -8[@
MQ)]\E I3:,DKN3/7]^A;/>ER WVK48KE+] @J6>!>T3UEL6"UY@MY.X> <"D
M,H>^NN)A0'1UE2NR:_!FOW0$X>MQR3=1UJ.F6  D%W27*9WBDU5;B\G@L"A@
MK0*%[^T5^KY-75+#0/,:"Y0DQCVT,G$;,_,<R_/R#2^^F;%M(J08M,M(E64$
M[06.L6<^;;DXDU[@=T]JW=R%CB?-6Q#/T[9M_UFIMM\N;O33=]SH<^I.P]"<
MCGO#R9O^F'!H;9[H6T-J7AR9C6FF;T\@GZ>0J_4DSFNK,<2IEFJV1!^E?/G.
M)'<;6BQ#KHEK/1#!MMEZ)CW_8M-JBWV]GX[>]<#B#$  !N?]X7DP[@^&O\%)
MA279G5JUCW:L'':L4TK/*+B%6D:;!'0T\:\P:8:]R,/@##TQ_6EAM1%Y:M6H
MEPUBD1:*TYIMM+6WC?D/-7HW8HPW,![ACC,,)?&]&DF*"N\[<3_F@!'LCBX/
M#,Z.N>!!96E-K^K1? )1[!,KL-B*(T5LXH$U>S)N#99M>Z?<%DCIQ5EN\J/,
MTEN*$<48S&Q3*AA;#^WVGDX26RODMU",4RS*:I5?8E9="=]JOBG*;!%30>K"
M.=0/S65)#7:'14SU%GY:B>-0HL)JC1>LX,WG;MKO'MXVB:>I3=P[/0JP8O"^
M."R1G9)UQ,C,@B*@O0:+UU3:>DCGM#P949=_4Z79%/^?T+=DO.LL=3"<N;<E
M.>4.);<M0DP93@W\#*>81%/I8&G6KQ2HD>!/64L"9*3:"@D<*QT[RUK6F&S+
M,-:RSCMH"8NY*HX6P182W25T,/C'KH #YTXO1*$QP<]<[[$S".$G"R'X_;/$
MOE;7TS@8#;=^A8ZI_T&I=<#*S2F-U,21=A#+.C( +[1%,Z&M=2X9[;J]&UU-
M15.8Z5#YUP8D40H$Q,3UB(I*P;Y*)<>PI:!08;.-PXJ77F6($(\DE%J;?"V&
M<;\<"ZG;V1,]TO0@.6CQ$DD:' %W+@5PK]QPX\S[YC!E0TZ*,A+$[.D'F+#Z
M?-U>*_H5S@=YNV@#PE"\2@3D$!(X6*.0Z(H',"L;OMF<C#_W+:%H_I;[85Y@
M^9V]FWB?2T7*[S<)>N/WT@_ R3^@(I6A)B X##%T^G N00(*Q[&78(;U@3.Y
M!&6=QT3>\8G$+D.19Y@D-V>X .TWHR(?4/^_C#X>@!BS]ZG[3'<X,_'9SPQJ
M0OU-:TX92T:-E%?N&98 G\8KENF__.;WAY-#EY?GWIO-@FG?@J#> TJ?ADZ1
M6P_\=DM_/H!*HM=2SXIUM[T+BKQ\WIHTX<5YT2R[42136GN8DXDCR?I:2]H7
ME: T*P*G*!Q9G?,-K%<ZOW.+YN%4ZJH"P@O')DVI4M(<IL*ARX&*4YU,KZN$
MZE*"7)JBI30_Y?WSG8O_1/XK"@+(.EZQ0#$S&.0':Y/*?1)RR0&*-^8=MQ>5
M+.[1_62\T.9<;$H2?KJ%K^"16X2+6.SF!DJ[[3S,"1^'=10[Q%9&T*_6]?/T
MY96!O@L^,7=?57^D0_RNRLR]^S$=@B+H!5#7N=UAE<V#(N8I69X<?9]8M_/G
M[\Z\UR34:4H9F\EB_.5JE=THSF5@C5T?]-QMWIT!"J?R>5A?9S:KO5.NV';5
MA<L>A'DM.-L91#<VMT%'7-JSH'*$Z/>)7K=I& 7!^B2KBPV!#@C#U43&Z#P2
MXZKAB\;S)B4M(.)NLTWH?;B<7#GWA@)J.F>:GEAD\XU_P1>Z+)N$>3)T4S!I
MLFU4U6\7H3L^^@[1?4[CVH0WC*5O[>I/O'FWVVGX(:5MN-H"DZ<\?Y9Y( 0-
MN2=^@Q'+IWA=U[@:T'!;^?4N4\7/!D6#PW#6V%QG#W?I->V5Q?+"S+::N%/M
M]5$PEL]F**7:O.=:U%E3]Y0D]VY3]*Z>*BAQ!3K18-R>HG&+YY8Y!LTM>] M
M:]M5,M>\E Q,1[.I:UGN%?$*_8E48.\R&9:16)Q*0>8J*79Q\:C;.!NB%.6U
MJET>R'7%T#NHS,).B_OL# !X-YB<]2\N>L/^Z/W."OD<'[''3RF;=-<X<N4J
MWK[-:*2;F'#'D2@QU8IOE:<=3+5[G+LSG5*%?2-\Q$73<I=EF =1JW_A20CH
M3<I3RI:["4O#'!G%W?_'97\XZ3N)CO9*6K1G(F;GJX^HL97G:"L)M7O&!VGJ
M''<Y14_3E <>>(2=$-/EM8IVK#G)F0J)> 9.S1R,ZC! CGUB;5?.QM)4=M,Q
M,7U:6H[F.AD:BS4U^1R'P1LYGB+4RQJG662;6>DS9 U7<!WQ91WS:&.H3*B$
M0TD 8Z^<[%,J4H_>0U%D<^Z <^&7&X$./=Q!?W:+,+C^ LU(,.U2,J)749Q0
M%I(T5[G0Q+O#X@='K>+S1*#1>+S<RMH8='#8@F@+"T\Q5V+67L=KYG,5;BVJ
MJ3T P86 UYM,N2K"ROMQ'=E:X1KE,<O+V!'>;4ZM-A.\MM<,M5:!QN(I.9=?
M-<NS#R![5\I=+[3JUVY P$3;%\2B-M<QXX"<X;)*8&/:\-=PPD/_[7G ?B'G
M]UG(W8MIMM*ET=S!NU!T<LEUM&BNDLZ%((1J5_6S?=!Z!ZK(A'F'(Z[[V#N;
M4AD>NCS"VI1@LER;9)5:>CW>"E/F&W/'7E'&1%V-'-KJTI7CF2IOB72>NA6O
M1:OX'J;,'-T,NY'D-.VCN3MC6?FM[;.]<[6Y]Y9R?!7?U)Q<ZS%S3W+EODQ9
MWK!W):STG&R^I<H=.X;?A8Z]^[@'5%1ZX-C>DNDF*;)H59+Z(S<7[/;$ 7KD
M4'7J-MH&\)P@4::P#S[M-E=4;]9=[EY.;=S\_'_><X@\>'^)Q4K?]H:_]B?!
M8%@M%!A=Z=L+&DN>S9.H<-6*D\0FMY#7+P%WKJO;=@\Y9[2)CP3'YUP0B&8D
M_YY7G89.<)S0N.U7E#ID-(Z(.T2_S^@5[K/?A^3 N"3G 0=LT^9PWB4OE:"D
M)5T)R&BH 0[GT1I^G,3_]J;'W#QNSHRPX="0HH#ZC1%='X\A1BZK+#>.H3+*
M$K H-",NRZ^B5!K$O_TNZ+O)=)@R=%@2DA6HL"2P@\URP13^60&>5$G'S,SQ
M>[498<#@BB#RAV0WV=O/\\T<PQS?,-IS_!WM^:PJ\)FY-9U4'FH\.K%'<O.$
ME[Q&MB3M1B1JG!D1(^,L2\S&-GNM69TTTDJIU)PI3>KA0-O8A>AX,5D5Z__F
MZ-_5F,+X22H[#;1W0:APH4J^\('J*_E92([%.ZQ^:2Q>/@/=[]DD=A0K6^#"
M[70M<@T%-\^CE#VN-8V8!UUUN)5>+?=^U#CE-M<F]#.P:NU(R2CO4#'96?79
MO<;P*)FO^J[IMA?+\27O;K#RO5JR7GD4G\$E]D6]@186%U9D\TJHM5?6].]I
M:JVLB4+>4E][F[AB339R4PE2]&J8.K>'[*1R$B@#4SIITN<J 4^/?NI5@):X
MX'SP=&$<$%BEU=JY2DVP/WU2>1. ;[1',OA<4H.E]I#L,X?21_O[@)"<!06@
MHT3J\A%Y2.S\"$[)JPV3N!M<":HIH[D8<D-39<%H(6B(G+PKMRC@ ^:>1!N\
MDZ)ZU51G6TG+HVE5<I_#+>ERAN.@@9#TGFK/FC!N3;6&F<_UR]IZR,XIXQ].
M[=]*6[SPVYK:EE?@@/W.7<?:!N;R+^SYN&#\UM$3:E-6,G&$MG[_!..=0 Z=
M@N!KS:<(#7R/E[%:Y+U%A:&H$:Y-"0&T,0@PJ ^$HG[,.EE+/VWHL&6-:8_)
M-;I$W:#<';>R5(7]T; N:/52&2G_NDZ"[7V0G3G6GK'?E&QE+O;46?6U1A]U
M8:H36$XSL,TC2WER[CYEW,I)HHW0A(Y=_DEU\K@08A'XZHOJ?!K]I6\,B2.=
MX%S?1'*M76$6V/N1D]ZKY0_$<NL$>B1HA)'+;&<^L:GH)3=]CEFP)\%X\.O;
MJ0,J"PN?'#0B4FBTQ%Z3[%U;2\B!:%R$7".J8X9FH$\$$CBEVZE>?-X \3G0
M1\Z]J'7"E!,B+Y>DFCPT=-1-@<:BZL1I)(^\0"0A0#?%J:/4Z4T14RZW<:ED
M4Y*'*/^V7J+^!$P0^ 2Y/4D,'J[^IE"8K>B5.(JXNARIZ8@K3&,73+L4DL.+
M&W=E*I@:1%1E$=/?+@:]UX.+P?0/<R^BW;K.Q<.2 \C7$V,,,:<]",N,%"4&
M\6G418EV*F57.ZK2C?&%'@UFH4$$(@VC(@NK04"942T;H4U,GIF2 R(_\DLZ
MGD*/"YG;:\2+-A00B3LKJ7R!^QE5BZW5(TAXMZ,G*%9F\VB4W-E=(*HQ4BWQ
M2H+"*QX2NN!@J(?G3)&9(7>"[/1H\J2AF=+=S"LLLL_E1F.!8N[,;=Z\0DX5
M 0/,RI%F8.T0F3.EE".BO:K+*<+QFBM=UD]]Q$4N\+R*XANQT'*5J$CN'554
M *QR#5=DMH684\[]X5K[2M)N42WGV%@D%TX::E\+:#8'>0PI=Y@++EKQJ#/S
M<3^$>@59'[%WR"<%'JL%V:F:H[>X87.36Y2:HUZQUV\8HCGY#M%\5E5KBBW]
M.OJM/QYBA<V+WN_V(+Z!#BXHK"INCI0 ,FZ.KJOHD<Z8]BAXOLLXLWJ*R&Y^
MU>'"XY:9@KE>I4RKO?BVA)LX45=6PWE%T9PW&&?MBB*ABFYR8EH>[T!VW1II
M')K?3/S:4D"6<P4?1_F.;GY%UL*17KFW_1Y61A7K"8F$UXHRMPN^%G5F_O2.
M$523H/-!C4K@ !;X1J6Q$FB">-C\!]KSM&ZY#EN#T&;,%>0 @RL<>BV<<L\N
M>V$'!(]C"SV D'N6Q*#25Y\?205B$PG^SS/PU;59OTE5"I,V5Z13J?B"CLK%
M*6V:2KFAD(%"\H%L:]6(7IPZFIJNB]4)%FB@VCR&EKM1:N_CGM!F=+JKJTYO
M*&)><CY3P9'A_V/GQ>GV\P*$8'3^!WSX=OKNXM7_ E!+ P04    " "]@Y56
MCG*3GT(#  !8"P  $    &AC82TR,#(S,#0Q.2YX<V2]5DUOVS@0O1?H?YCJ
MM M4HF4G02TD*;J;!@B0IH6;+O96T-+8)I8BM225Q/^^0TIR9"=VG:2H+J(X
M\V;>?'"HX_=WI80;-%9H=1*ER2 "5+DNA)J?1+6-N<V%B-Z?OGYU_":.X>S\
MX@IB6#A7V8RQV]O;I)@)9;6L'5FP2:Y+!G'<Z?]]_0W^::QG,$&)W"*4W#HT
M\%<M9)$-!\-AF@[>)4=]F$'N[4'!'69PP(8I(\41'&6C@^QP %\^P<=@1<&U
M*+$/U=72B/G"P1_YGQ! 9UHIE!*7<"X45[G@$KYVC-_"A<H3^" E3#S,$DV+
MY@:+I+5Z9XO,Y@LL^>M7 )0O93-%)NOR)/*):/-P-S4RT6;."F>86U;(2"DF
M+30BCWK0G^,>8*@07F)7P!FWTP#J)#X]PQYBD?,U+_2]0"X=O0V&*OG4# [2
M<0]4H%B! BV+>3+7-XP$FPZ\7#P>R' P&#%J"D>YQAY$"O7?#H073ZD_^DX>
M0&Y' 9".QV,6I!N4"K<>06O]D#7"H,V=,V):.SS7ICS#&:\EH6KU?\VEF DL
M@A8U:XG*K>FL:SANYNBN>(FVXCD^/=_468\%1WQ3]N^GRZ^AZ:)3#P (?2C*
M2AL'33M>ZCR<DATY]5]Q5XK8;\7I,!ZE"1F+0#U*?4L=@;V82%?A9Q%9M<?>
M1.RV-O:+V"^V>7^\^9^=@<V3[>,?^_C3H[WB?S 9?@$3K:Y>2J8WWIY?$\5%
MWDRO9KE_7>Z1+^K-;C3X/!SN=+PY2UJOP2=72KO@J,^$5Y50,]UNT:9OXJSK
MY G.(,RPC)O<:(F[)QVKC*[0.$'3_OXP- 86!F>$SGG<C9GODD\3&C.=Q@/[
MZZ?+BQE!4%[>L^NP3C@/OO1B\'*Z-;E<F?;=<!)92KOLG<[?&VU%4_:)T1+$
MTH /1=L>])>>UI-C]WZN20/\XMODXB=7Q.J.8([?::7+9</T3.>UOXNZ]P=5
M?%3$;WE!S67*P"T"09?)A-2_[Z6^8MIQ+9!^Y$3HX'3@'_K/ZRSTEUP5T)B#
MGKUCMFEDTWYML?BL3L,ZYS*OY2KS+;C5V 7<K-G^R'MFVW'M;E>U[B2SS:/<
M[O2/?+/5C!SZ_ %02P,$%     @ O8.55B4EI)5<!@  OD,  !0   !H8V$M
M,C R,S T,3E?;&%B+GAM;,V<;V_;-A#&WQ?H=[AY;S:@LF.G*Q:C:9$YR1 L
M;8+$W88-0R%+C$U,(@U23NQO/U)_&CFF9"H\37G15I'NGKM'_IU*RW+>?US'
M$=P3(2EGQ[UA_Z 'A 4\I&Q^W%M)SY<!I3V0B<]"/^*,'/<V1/8^?GC]ZOUW
MG@>GYQ>?P8-%DBSE>#!X>'CHAW>421ZM$B4I^P&/!^!Y1?QD^@5^S\J-X89$
MQ)<$8E\F1, O*QJ%X]'!:#0<'OS<?U=.$\37>A#Z"1G#V\%H.%"!A_!N?/AV
M_-,!7'^"LU2%P93&I)S*EQM!YXL$?@A^A#3IE#-&HHALX)PRGP74C^"VZ/@-
M7+"@#R=1!#<Z3:HV)1'W).SGJA%E_X[U7S/=/+Q^!:#.(I/ION.>/A?YJ5C/
M1-3G8JYZ/3@<%"F]QXSU3LK#89HP/#HZ&J1'R]&2FF*5^'#PYZ?+VV!!8M]3
M9U^]6D%>1M*Q3/=?\B ]A18-0F6$_LDKPCR]RQN.O,-A?RW#W@==,#\[_HQ$
MEVH+4@]CP2-24U@?3JOW\OADLU3Q9)T0%I)<^9LV#_*HA2!WF:IF+Y64).C/
M^?T@)%0#,M(;GM[0'7ZO?O@ZX0KWDYE,A!\DV_4B?8JX*':F)HY[AJ3!=D,Z
M[D0$6UJ^" H=M;G'?QXQ"+AZW9:)ERH6Z7>"Q\8N\G+<</!K-(N,;6J2U):>
M;L*\+[?[O&9"96."2+X2"J\F+VWJYT.J#'\7VO^\'SS6?BFMJDN())=-^W5#
M\B16F*L_R7GDSVV1?)+4$9+FUKGAH N2!B$D)+\I@Y9V!K*%1LM VG;KAN,9
M2VBRF:@RPH\NU 5X_1O9V&)9D=P1GO56>$V0"ZXU@DC89A4@+P%I#5!%G %N
ML?4RR,W[=T/ZE <K/3=3U;TMR=LY'0%L;)SO'G/!=5<'B=)"&+2R,YKX;9:)
MM.P5!\-K(B@/SUAXJM[.-.7Q27+'8)JM\)H@#%0-@MC,9B5 U0!=! W?%EHW
M<FS=/\9BX8;,J5XDL^2S'UL3;<[M=*E08817Q[@O%$QZN.N$QPJ@2R"M$MKH
MV[!(L&X> ^0+%G"QY"*]57*;J,&9\)5:I&PF/&S(]1ZI3C&WL\FM4]R'P$(>
M=R:V"D):$?*2H&LB#<G_X,LP,\\WAS%$YS0BGU?QC(AF$U/.ZW0\# :X^;@[
M^$^U<"G7ZI#)(P&-W:^!7JNF,4"=^NN+4"V6Z!W-;HX_A]I*D4X1WF>-6P2[
MPUTKC$NZ*@7;M7"Y;]6*80B>X0=C)$["4!F0^3^7E)%ALW$P"G0Z"G66^)Y
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M:,/P(9^ME_*.2[6E?^]$OHMFOWU![?D/4$L#!!0    ( +V#E5;GQSFOM@0
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MV0  #@              @ $     9#0R,S4P,V0X:RYH=&U02P$"% ,4
M" "]@Y56KZ1:?\\R  !:X0  $0              @ '(%@  9#0R,S4P,V1E
M>#$P,2YH=&U02P$"% ,4    " "]@Y56CG*3GT(#  !8"P  $
M    @ '&20  :&-A+3(P,C,P-#$Y+GAS9%!+ 0(4 Q0    ( +V#E58E):25
M7 8  +Y#   4              "  39-  !H8V$M,C R,S T,3E?;&%B+GAM
M;%!+ 0(4 Q0    ( +V#E5;GQSFOM@0  (4J   4              "  <13
L  !H8V$M,C R,S T,3E?<')E+GAM;%!+!08     !0 % #T!  "L6      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
